{"ORPHApacket":[{"ORPHApacketID":"404","date":"2019-12-06 08:34:03","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"404","Name":[{"lang":"en","label":"Familial hyperaldosteronism type II"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_404","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Adrenal\/paraganglial tumor"}],"ORPHA":"100091","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_100091"},{"Name":[{"lang":"en","label":"Familial hyperaldosteronism"}],"ORPHA":"235936","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_235936"},{"Name":[{"lang":"en","label":"Genetic neuroendocrine tumor"}],"ORPHA":"271847","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_271847"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Familial hyperaldosteronism type II (FH-II) is a heritable form of primary aldosteronism (PA) characterized by hypertension of varying severity, and non glucocticoid remediable hyperaldosteronism."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"605635","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]}]}],"SynonymList":[{"count":"4","Synonym":[{"lang":"en","label":"FH-II"},{"lang":"en","label":"FH2"},{"lang":"en","label":"Familial adrenal adenoma"},{"lang":"en","label":"Familial hyperaldosteronism type 2"}]}],"HPODisorderAssociationList":[{"count":"14","HPODisorderAssociation":[{"HPOId":"HP:0000822","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000822","HPOTerm":"Hypertension","HPOFrequency":[{"ORPHA":"453310","Name":[{"lang":"en","label":"Obligate (100%)"}]}]},{"HPOId":"HP:0011740","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011740","HPOTerm":"Glucocortocoid-insensitive primary hyperaldosteronism","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0040084","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0040084","HPOTerm":"Abnormal circulating renin","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0011746","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011746","HPOTerm":"Secretory adrenocortical adenoma","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0000360","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000360","HPOTerm":"Tinnitus","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000421","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000421","HPOTerm":"Epistaxis","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001324","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001324","HPOTerm":"Muscle weakness","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002018","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002018","HPOTerm":"Nausea","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002170","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002170","HPOTerm":"Intracranial hemorrhage","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002315","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002315","HPOTerm":"Headache","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002900","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002900","HPOTerm":"Hypokalemia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0008221","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008221","HPOTerm":"Adrenal hyperplasia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0200114","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0200114","HPOTerm":"Metabolic alkalosis","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0011739","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011739","HPOTerm":"Dexamethasone-suppresible primary hyperaldosteronism","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}